INO - Inovio Pharmaceuticals Inc
IEX Last Trade
7.21
-0.110 -1.526%
Share volume: 207,284
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.32
-0.11
-1.50%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-01 | 2023-05-10 | 2023-08-09 | 2023-11-09 | 2024-03-06 | 2024-05-13 | |
| Total revenue | 784.395 K | 9.154 M | 124.666 K | 114.943 K | 225.971 K | 388.446 K | 102.650 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 784.395 K | 9.154 M | 124.666 K | 114.943 K | 225.971 K | 388.446 K | 102.650 K | 0.000 | |
| 1,067.03% | -98.64% | -7.80% | 96.59% | 71.90% | -73.57% | -100.00% | |||
| Operating expenses | 104.922 M | 44.911 M | 56.071 M | 44.067 M | 37.267 M | 25.428 M | 27.496 M | 31.485 M | |
| Selling general and admin | 48.457 M | 11.824 M | 13.951 M | 13.891 M | 13.523 M | 9.925 M | 10.243 M | 10.571 M | |
| Research and development | 56.465 M | 33.087 M | 42.120 M | 30.177 M | 23.744 M | 15.503 M | 17.253 M | 20.914 M | |
| Total expenses | 105.856 M | 45.216 M | 56.194 M | 44.067 M | 37.267 M | 25.428 M | 26.723 M | 31.611 M | |
| -57.29% | 24.28% | -21.58% | -15.43% | -31.77% | 5.09% | 18.29% | |||
| Operating income | -105.071 M | -36.062 M | -56.069 M | -43.952 M | -37.041 M | -25.040 M | -26.621 M | -31.611 M | |
| Ebit | -105.071 M | -36.062 M | -58.234 M | -43.336 M | -36.884 M | -24.825 M | -27.608 M | -31.611 M | |
| Pretax income | -108.497 M | -37.784 M | -56.628 M | -40.649 M | -35.535 M | -33.930 M | -25.004 M | -30.470 M | |
| -65.18% | 49.87% | -28.22% | -12.58% | -4.52% | -26.31% | 21.86% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -108.497 M | -37.784 M | -54.463 M | -40.649 M | -35.535 M | -33.930 M | -25.004 M | -30.470 M | |
| 65.18% | -44.14% | 25.36% | 12.58% | 4.52% | 26.31% | -21.86% | |||
| Net income | -108.497 M | -37.784 M | -54.463 M | -40.649 M | -35.535 M | -33.930 M | -25.004 M | -30.470 M | |
| 65.18% | -44.14% | 25.36% | 12.58% | 4.52% | 26.31% | -21.86% |